MINISTRY OF HEALTH

PHARMACY DEPARTMENT

APRIL 2020 FACILITY TRACER MEDICINES STOCK STATUS REPORT

A Publication of the Ministry of Health

This monthly report on the facility stock status of the 41 tracer items (in different baskets) provides information about the stock situation of health facilities in the country in order to inform the Ministry of Health and all stakeholders to make appropriate logistics decisions that ensure an effective health commodities supply chain.

The report shows the number and percentages of facilities that are appropriately stocked, over stocked or out of stock by level of care and ownership based on Months of Stock (MOS). The MOS highlights the number of months a product will last based on the present consumption rate. It also further indicates facilities that have over 8 months of stock (MOS) broken down by level of care and ownership.

The report shows the availability of the different and overall baskets using two indicators i.e. 1) Average percentage availability of a basket of 41 commodities based on all reporting facilities in the previous cycle Definition : Availability is measured as the number of days for which a specific commodity was in stock at the facility store during the reporting period. 2) Percentage of facilities that had over 95% availability of a basket of commodities in the previous cycle Definition : This indicator measures the % of health facilities that reported having the basket of commodities available during the reporting period.

The contents of the different baskets are listed below: ARV BASKET LOC EMHS BASKET LOC Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/ 600mgHC2 Artemether/Lumefantrine 20/120 mg HC2 AZT/3TC/NVP 300mg/150mg/200mg HC2 Therapeutic milk F75 (75Kcal/100ml) Hospital Atazanavir/ritonavir(ATV/r)300/100mg table* HC3 Oral Liquid Morphine 5ml/ml* HC3 Tenofovir/Lamivudine (TDF/3TC) 300mg/300mg* HC3 Ready to use Therapeutic feeds (RUTF) HC2 TDF/3TC/DTG 300mg/300mg/50mg(TLD)* HC3 Cotrimoxazole 960mg tablet HC2 TLE 300mg/300mg/400mg HC2 Chlorhexidine Digluconate Gel 7.1% HC2 Abacavir/Lamivudine (ABC/3TC) 120mg/60mg (Paediatric) HC3 Bendrofulazide (Aprinox) 5mg HC3 Lopinavir40mg/ritonavir 10mg pellets in capsules* HC3 Artesunate 60mg* HC3 Nifedipine tablets 20mg tablet HC3 LAB BASKET LOC Captopril 25mg tablet HC4 Determine HIV 1 & 2 screening test HC2 Metformin 500mg HC3 Stat -pack HIV Confirmatory rapid tests, tests HC2 Glibenclamide 5mg tablet HC4 SD Bioline test-Tie Breaker HC2 Insulin short-acting HC4 CD4 reagent HC4 Cardiac Aspirin 75/80 mg HC4 Malaria Rapid Diagnostic tests HC2 GeneXepert Catridges* HC3 Blood 450 ml HC4

RMNCAH BASKET LOC TB BASKET LOC Depot medroxy progesterone acetate (DMPA) HC2 (RHZE) blister strip 150/75/400/275 mg HC3 Amoxicillin 250 mg capsule* HC2 RHZ Blister 75mg/50mg/150mg HC3 Sulfadoxine/ Pyrimethamine tablet HC2 ORS Sachets with zinc tablet HC2 Measles-Rubella Vaccine HC2 Misoprostol 200mcg Tablet HC2 Amoxicillin dispersible 250mg tablet HC2 Ceftriaxone 1g Injection HC3 Oxytocin Injection HC3 Note: * New commodity Mama Kit HC2 With the revision of the HMIS tools and change in treatment guidelines a total of eight new commodities were introduced.

KEY FINDINGS 1. The average facility reporting rate per district for the month of April 2020 on HMIS-105:6 (Stock status) was at 77% and nationally it was at 54% (4001/7478). •A total of fifteen districts had 100% reporting for all their facilities while 5 districts had less than 50% of their facilities reporting. Notably, the least being Rubirizi, Kayunga, Mukono, Wakiso, and •Out of the 14 Regional Referral Hospitals; four submitted complete reports and 5 submitted incomplete reports on the 41 tracer commodities. •Arua, Hoima, Mbale, Jinja and Mubende Regional Referral Hospitals did not submit report on the 41 tracer commodities. 2. Overall average availability for the basket of 41 tracer commodities was 81% (n=1583), indicating no change from the month of March 2020 which was 81% (n=1673). a) TB commodities had better availability of 86% (n=689) than other baskets while ARV basket had the least with 71% (n=1137) availability. b) An average of 55% (n=1583) of facilities reported over 95% availability of commodities, decreasing from the month of March 2020 which was 56% (n=1673). 3. Ready to use Therapeutic feeds, TLE 300mg/300mg/600mg, CD4 reagent, SD-Bioline test and Oral Liquid Morphine 5ml/ml were stocked-out in most health facilities. 4. ACTs and Malaria Rapid Diagnostic tests commodities were overstocked in 48% and 42% respectively in Government HCII, HCIII and HCIV facilities. 5. Determine HIV test and RHZ Blister were expired in 19% and 8% of the health facilities respectively. Most being in HCII and HCIII facilities. 6. Measles Vaccine and Determine HIV test had higher cost value for expiry amounting to 664,024,691 shillings and 455,554,842 shillings respectively.

ACTION POINTS 1. Pharmacy Department working with regional IPs to ensure that all facilities get adequate stock of legacy regimens from central warehouses. 2. Pharmacy Department will continue monitoring the blood stock levels to inform blood bank decisions for improved blood availability. 3. Pharmacy Department to target their supervisions to the poor performing Regional Referral Hospitals and health facilities 4. Work with the IPs to prioritize and strengthen health facility reporting and quality of data especially for quantity expired. Quality Assurance of the data submitted should be prioritized. 5. Pharmacy Department to support health facilities to report using the new HMIS tools. There is a plan to conduct Regional and Facility Based HMIS Training. This should impove the reporting rate and quality of reports submitted.

April 2020 Facility Stock Status Report 1 of 10 AVAILABILITY INDICATORS

Percentage Average Availability of Basket of commodities Dec'18 -Apr'20 Percentage of facilities with over 95% availability of commodities 90 90 Dec'18-Apr'20

80 80

70 70

60 60

50 50

40 40

30 30

20 20 Dec'18- Feb- Apr- Aug- Oct- Dec'18- Feb- Apr- Aug- Oct- Jun-Jul'19 Jan-20 Feb-20 Mar-20 Apr-20 Jun-Jul'19 Jan-20 Feb-20 Mar-20 Apr-20 Jan'19 Mar'19 May'19 Sep'19 Nov'19 Jan'19 Mar'19 May'19 Sep'19 Nov'19 EMHS (14 items) 77 84 81 77 75 76 81 84 83 81 EMHS (14 items) 43 48 44 39 38 39 56 59 58 57 ARV (8 items) 74 76 76 75 72 72 74 74 73 71 ARV (8 items) 42 41 42 42 37 35 43 42 43 39 LAB (7 items) 82 87 86 84 84 84 82 83 83 84 LAB (7 items) 53 59 57 54 53 54 57 57 59 63 TB (2 items) 66 87 88 87 86 85 84 85 87 86 TB (2 items) 51 71 72 70 66 67 74 75 77 75 RMNCAH (10 items) 82 85 85 82 83 85 78 82 81 81 RMNCAH (10 items) 39 45 44 40 42 45 36 41 41 42

Percentage availability for each item (EMHS basket) Percentage availability for each item (ARV basket) Item n % availty % expiryItem n % availty % expiry 7 Artemether/Lumefantrine 20/120 mg 1893 94% 4.4% Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/1042 76% 600mg 1.6% 8 Therapeutic milk F75 (75Kcal/100ml) 39 56% AZT/3TC/NVP 300mg/150mg/200mg 944 73% 2.0% 11 Oral Liquid Morphine 5ml/ml 301 11% 0.2% Atazanavir/ritonavir(ATV/r)300/100mg table 668 80% 2.2% 12 Ready to use Therapeutic feeds (RUTF)647 36% 0.7% Tenofovir/Lamivudine (TDF/3TC) 300mg/300mg 677 91% 4.8% 14 Cotrimoxazole 960mg tablet 1054 75% 1.0% TDF/3TC/DTG 300mg/300mg/50mg(TLD) 709 95% 1.6% 15 Chlorhexidine Digluconate Gel 7.1% 967 71% 2.0% TLE 300mg/300mg/600mg 557 15% 0.6% 16 Bendrofulazide (Aprinox) 5mg 673 86% 2.1% Abacavir/Lamivudine (ABC/3TC) 120mg/60mg (Paediatric)660 89% 3.1% 19 Artesunate 60mg 744 88% 1.7% Lopinavir/ritonavir 40mg/10mg pellets in capsules 605 72% 4.3% 20 Nifedipine tablets 20mg tablet 716 80% 1.4% 23 Captopril 25mg tablet 145 70% 2.0% 27 Metformin 500mg 642 76% 1.5% Percentage availability for each item (TB basket) 30 Glibenclamide 5mg tablet 150 82% 3.3% Item n % availty % expiry

32 Insulin short-acting 126 63% 3.5% 4 (RHZE) blister strip 150/75/400/275 mg 660 91% 1.8%

37 Cardiac Aspirin 75/80 mg 142 67% 2.7% 31 RHZ Blister 75mg/50mg/150mg 586 80% 7.6% 38 38 38 38 38 38 38 38 38 38

Percentage availability for each item (RMNCAH basket) Percentage availability for each item (LAB basket) Item n % availty %Item expiry n % availty % expiry Depot medroxy progesterone acetate1400 (DMPA) 67% 2.4% 2 Determine HIV 1 & 2 screening test 1463 85% 18.8% Amoxicillin 250 mg capsule 1834 83% 1.8% 9 Stat -pack HIV Confirmatory rapid tests, tests 1204 77% 2.7% Sulfadoxine/ Pyrimethamine tablet 1662 86% 2.8% 10 SD Bioline test-Tie Breaker 1005 63% 4.4% ORS Sachets with zinc tablet 1767 89% 1.7% 17 CD4 reagent 90 47% 6.1% Measles-Rubella Vaccine 1307 88% 2.0% 33 Malaria Rapid Diagnostic tests 1771 94% 4.1% Misoprostol 200mcg Tablet 1235 86% 5.8% 39 GeneXepert Catridges 88 70% 0.0% Amoxicillin dispersible 250mg tablet 1405 78% 1.4% 40 Blood 450 ml 87 57% 6.3% Ceftriaxone 1g Injection 736 84% 1.3% Oxytocin Injection 657 74% 1.6% Mama Kit 957 63% 1.0% Note: % expiry - percentage of facilities the reported on expiry

DISTRICT LEAGUE TABLE

Note: The district league table ranks districts based on the percentage of facilities with over 95% availability within the district.

Avg N: Is the average number of facilities that reported on the basket of commodities in the respective districts.

A zero (0) in the table implies that no facility in the respective district had over 95% availability of a given basket of commodities.

100% from the district league table implies that all facilities in the respective district had over 95% availability of a given basket of commodities.

A blank in the leaugue table implies that all facilities in the district submitted incomplete reports for a given basket of commodities.

April 2020 Facility Stock Status Report 2 of 10 District League Table1 (Percentage of Facilities with over 95% availability by District)

Facilities Reporting Facilities Reporting Overall Overall Avg Rank District EMHS ARV LAB RMNCAHTB Avg Avail Avg N Total N % reporting Rank District EMHS ARV LAB RMNCAH TB Avail Avg N Total N % reporting 1 94% 100% 100% 69% 100% 93% 30 34 88% 69 42% 30% 57% 45% 73% 49% 56 87 64% 2 96% 71% 96% 72% 100% 87% 26 27 96% 70 38% 50% 63% 44% 50% 49% 34 116 29% 3 Kampala District 85% 85% 86% 81% 92% 86% 109 1688 6% 71 63% 33% 33% 14% 100% 49% 18 28 64% 4 100% 100% 50% 75% 100% 85% 16 16 100% 72 53% 50% 65% 16% 60% 49% 26 26 100% 5 90% 100% 80% 50% 100% 84% 21 22 95% 73 33% 22% 73% 33% 80% 48% 39 49 80% 6 91% 80% 82% 55% 100% 81% 18 32 56% 74 52% 30% 70% 29% 56% 47% 23 36 64% 7 100% 100% 100% 0% 100% 80% 30 32 94% 75 33% 17% 47% 60% 78% 47% 15 19 79% 8 77% 71% 77% 85% 88% 79% 27 50 54% 76 41% 43% 41% 39% 70% 47% 26 33 79% 9 77% 84% 83% 57% 93% 79% 85 127 67% 77 40% 50% 50% 47% 20 23 87% 10 73% 79% 73% 77% 90% 79% 47 80 59% 78 39% 44% 42% 26% 80% 46% 74 106 70% 11 92% 67% 96% 58% 80% 78% 24 27 89% 79 40% 19% 57% 30% 83% 46% 30 32 94% 12 50% 100% 33% 100% 100% 77% 13 16 81% 80 50% 25% 50% 0% 100% 45% 40 57 70% 13 73% 75% 90% 70% 71% 76% 31 41 76% 81 57% 67% 17% 17% 67% 45% 34 55 62% 14 73% 59% 83% 61% 100% 75% 56 75 75% 82 Luwero District 30% 17% 49% 36% 89% 44% 58 89 65% 15 50% 100% 50% 100% 75% 26 51 51% 83 65% 0% 81% 44% 29% 44% 27 34 79% 16 83% 75% 80% 36% 100% 75% 21 39 54% 84 25% 0% 67% 25% 100% 43% 20 39 51% 17 82% 57% 50% 83% 100% 74% 57 68 84% 85 54% 38% 25% 25% 75% 43% 25 29 86% 18 69% 71% 75% 72% 83% 74% 58 74 78% 86 36% 39% 43% 21% 67% 41% 14 23 61% 19 74% 63% 83% 64% 88% 74% 28 46 61% 87 42% 27% 36% 58% 40% 41% 14 14 100% 20 Kalaki District 75% 44% 92% 58% 100% 74% 12 12 100% 88 52% 19% 60% 42% 30% 41% 44 50 88% 21 70% 79% 65% 52% 100% 73% 28 41 68% 89 20% 33% 33% 31% 75% 38% 26 29 90% 22 91% 80% 90% 55% 50% 73% 87 93 94% 90 36% 25% 46% 27% 57% 38% 40 47 85% 23 76% 56% 80% 52% 100% 73% 22 29 76% 91 42% 6% 42% 24% 75% 38% 42 51 82% 24 69% 60% 79% 71% 80% 72% 30 39 77% 92 35% 33% 45% 20% 56% 38% 42 71 59% 25 75% 75% 100% 58% 50% 72% 23 36 64% 93 35% 9% 29% 26% 83% 37% 25 28 89% 26 84% 71% 83% 47% 67% 71% 20 24 83% 94 60% 0% 0% 20% 100% 36% 20 26 77% 27 62% 67% 78% 69% 67% 68% 13 15 87% 95 40% 20% 22% 20% 75% 35% 32 37 86% 28 80% 20% 84% 55% 100% 68% 39 40 98% 96 50% 25% 33% 0% 67% 35% 6 6 100% 29 73% 40% 87% 60% 78% 68% 15 17 88% 97 Kassanda District 0% 0% 100% 33% 33% 28 33 85% 30 90% 50% 73% 42% 83% 68% 24 44 55% 98 47% 0% 40% 19% 60% 33% 16 16 100% 31 68% 69% 54% 39% 100% 66% 27 37 73% 99 17% 7% 29% 11% 100% 33% 18 18 100% 32 81% 50% 50% 47% 100% 66% 56 65 86% 100 33% 0% 50% 75% 0% 32% 20 24 83% 33 Madi-Okollo District 58% 54% 68% 63% 82% 65% 19 19 100% 101 33% 8% 35% 5% 75% 31% 19 22 86% 34 75% 60% 69% 38% 83% 65% 17 19 89% 102 25% 100% 0% 0% 31% 8 10 80% 35 67% 33% 63% 60% 100% 65% 47 57 82% 103 50% 0% 0% 0% 100% 30% 9 9 100% 36 67% 50% 67% 50% 80% 63% 19 22 86% 104 25% 0% 50% 25% 50% 30% 18 18 100% 37 33% 50% 63% 67% 100% 63% 31 53 58% 105 0% 0% 50% 0% 100% 30% 40 40 100% 38 63% 23% 79% 54% 90% 62% 28 35 80% 106 0% 17% 0% 33% 100% 30% 30 56 54% 39 75% 13% 80% 55% 86% 62% 20 21 95% 107 27% 10% 23% 7% 75% 28% 17 17 100% 40 65% 25% 68% 61% 89% 62% 25 35 71% 108 38% 29% 11% 10% 50% 27% 22 26 85% 41 57% 33% 84% 48% 86% 62% 69 79 87% 109 44% 9% 58% 11% 11% 27% 76 611 12% 42 62% 50% 58% 36% 100% 61% 19 20 95% 110 10% 8% 29% 14% 73% 27% 52 59 88% 43 71% 50% 64% 43% 75% 61% 14 18 78% 111 14% 0% 17% 0% 100% 26% 38 45 84% 44 50% 0% 100% 50% 100% 60% 42 42 100% 112 22% 11% 21% 16% 60% 26% 65 119 55% 45 76% 37% 69% 36% 79% 59% 51 63 81% 113 0% 0% 25% 0% 100% 25% 13 15 87% 46 54% 29% 68% 58% 88% 59% 31 43 72% 114 67% 0% 0% 22% 25 31 81% 47 50% 50% 57% 59% 80% 59% 23 28 82% 115 0% 20% 40% 0% 50% 22% 25 28 89% 48 63% 44% 76% 33% 75% 58% 23 28 82% 116 0% 0% 25% 33% 50% 22% 16 17 94% 49 46% 55% 80% 26% 83% 58% 28 36 78% 117 0% 0% 0% 0% 100% 20% 17 23 74% 50 72% 31% 77% 39% 70% 58% 40 47 85% 118 0% 0% 0% 0% 100% 20% 23 34 68% 51 11% 43% 57% 71% 100% 57% 16 25 64% 119 20% 0% 67% 7% 0% 19% 39 54 72% 52 82% 50% 63% 36% 50% 56% 46 67 69% 120 0% 50% 0% 17% 11 13 85% 53 57% 40% 50% 52% 82% 56% 29 46 63% 121 0% 50% 0% 17% 24 29 83% 54 59% 52% 63% 37% 67% 56% 46 69 67% 122 Kitagwenda District 0% 0% 25% 0% 50% 15% 15 22 68% 55 57% 38% 62% 38% 83% 55% 58 71 82% 123 0% 0% 10% 11% 50% 14% 13 13 100% 56 71% 60% 62% 29% 50% 54% 22 27 81% 124 0% 0% 22% 0% 40% 12% 9 13 69% 57 57% 25% 84% 39% 67% 54% 49 55 89% 125 0% 33% 0% 11% 42 46 91% 58 55% 31% 69% 38% 78% 54% 33 40 83% 126 0% 0% 0% 0% 50% 10% 24 30 80% 59 44% 39% 71% 50% 67% 54% 24 89 27% 127 20% 0% 20% 0% 10% 18 29 62% 60 40% 50% 40% 40% 100% 54% 16 20 80% 128 0% 0% 0% 0% 33% 7% 47 57 82% 61 52% 31% 62% 57% 67% 54% 21 42 50% 129 100% 18 21 86% 62 56% 40% 50% 44% 75% 53% 17 20 85% 130 22 31 71% 63 33% 33% 60% 38% 100% 53% 38 62 61% 131 7 11 64% 64 83% 0% 60% 67% 53% 36 64 56% 132 15 24 63% 65 48% 46% 48% 29% 89% 52% 29 41 71% 133 13 31 42% 66 54% 44% 46% 31% 83% 52% 13 13 100% 134 20 22 91% 67 43% 25% 89% 25% 75% 51% 13 15 87% 135 13 26 50% 68 100% 0% 50% 50% 15 27 56%

League table 2: Regional Referral Hospitals Reporting on 41 Tracer Over 95% availability of a basket of commodities commodities (Stock status) Overall Regional Referral Hospital EMHS ARV LAB RMNCAH TB Avg Avail Total N % reporting 1 Arua RRH NR NR NR NR NR NR 2 China Uganda Friendship RRH 93% 66% 81% 100% 100% 88% 38 92% 3 RRH 57% NR NR 60% 58% 20 48% 4 Gulu RRH 96% 75% 56% 91% 100% 84% 41 100% 5 Hoima RRH NR NR NR NR NR NR 6 Jinja RRH NR NR NR NR NR NR 7 Kabale RRH 95% 72% 86% 78% 100% 86% 41 99% 8 Lira RRH 74% 89% 40% 41% 100% 69% 37 90% 9 Masaka RRH NR NR NR NR NR 20 48% 10 Mbale RRH NR NR NR NR NR NR 11 Mbarara RRH 100% NR NR NR NR 100% 2 5% 12 Moroto RRH 100% 100% 100% 100% 100% 100% 41 100% 13 Mubende RRH NR NR NR NR NR NR 14 Soroti RRH 100% 100% 78% 90% 100% 94% 41 100% Note: Blank cell (NR)- No Report on the 41 Tracer commodities (Stock status Section)

April 2020 Facility Stock Status Report 3 of 10 EMHS BASKET

Note: No: is the number of facilities Note: Pink shows the stock levels are stocked out or overstocked and need attention Row %: is the percentage of facilities Green: means the stock levels are adequate Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty ($) ACT (Artemether/Lumefantrine 100/200mg) Artemether/Lumefantrine 100/200mg Artemether/Lumefantrine 100/200mg Level of Care Level of Care Level of Care Clinics 9 14 26 41 10 16 18 29 63 100 Clinics 1 7 3 11 Clinics 1 30 1 HC 2s 98 10 316 32 112 11 456 46 982 100 HC 2s 273 8 34 315 HC 2s 47 159,967 6,399 HC 3s 36 6 187 31 82 14 298 49 603 100 HC 3s 185 1 34 220 HC 3s 19 109,390 4,376 HC 4s 4 5 19 23 14 17 46 55 83 100 HC 4s 23 0 5 28 HC 4s 7 42,574 1,703 Gen Hosp 5 8 16 26 9 15 32 52 62 100 Gen Hosp 15 1 8 24 Gen Hosp 4 2,643 106 RRH 0 0 0 0 2 33 4 67 6 100 RRH 4 0 0 4 RRH 1 22,320 893 NRH 0 0 0 0 1 50 1 50 2 100 NRH 1 0 0 1 NRH 1 6,480 259 Total 152 8 564 31 230 13 855 48 1801 100 Total 502 17 84 603 Grand Total 80 343,404 13,736 Ownership Comments: ACT (Artemether/Lumenfantrine 100/200mg) Government 119 9 363 27 166 12 692 52 1340 100 •8% and 31% of the facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 15 10 94 63 17 11 24 16 150 100 •48% of the facilities were overstocked (> 4 MoS). Govt owned HC2 & HC3s formed the larger part of the overstocked (> 8 MoS) PNFP 18 6 107 34 47 15 139 45 311 100 •A total of 80 health facilities reported on 343,404 quantity expired of ACT tablets, the majority of the health facilities with Total 152 8 564 31 230 13 855 48 1801 100 expiries being HC2s and HC3s. Value of unit cost $13,736

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty Therapeutic milk F75 (75Kcal/100ml) Therapeutic milk F75 (75Kcal/100ml) Therapeutic milk F75 (75Kcal/100ml) Level of Care Level of Care Level of Care Gen Hosp 16 55 4 14 3 10 6 21 29 100 Gen Hosp 3 3 3 RRH 0 0 0 0 1 20 4 80 5 100 RRH 3 3 3 Total 16 47 4 12 4 12 10 29 34 100 Total 6 6 6

Ownership Comments: Therapeutic milk F75 (75Kcal/100ml) Government 11 46 3 13 2 8 8 33 24 100 •47% and 12% of the facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PNFP 5 50 1 10 2 20 2 20 10 100 •29% of the facilities were overstocked (> 4 MoS). Total 16 47 4 12 4 12 10 29 34 100 •None of the facilities reported on expiry of Therapeutic milk F75 (75Kcal/100ml)

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per bottle No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Oral Liquid Morphine 5ml/ml Oral Liquid Morphine 5ml/ml Oral Liquid Morphine 5ml/ml Level of Care Level of Care Level of Care HC 3s 199 99 1 1 1 1 1 1 202 100 HC 3s 0 1 1 HC 4s 51 94 1 2 1 2 1 2 54 100 HC 4s 1 0 1 Gen Hosp 1 19 173,717 Gen Hosp 20 57 5 14 5 14 5 14 35 100 Gen Hosp 2 0 2 Total 1 19 173,717 RRH 1 25 0 0 1 25 2 50 4 100 RRH 1 0 1 Total 271 92 7 2 8 3 9 3 295 100 Total 4 1 5

Ownership Comments: Oral Liquid Morphine 5ml/ml Government 224 93 5 2 4 2 7 3 240 100 •92% and 2% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 1 50 1 50 0 0 0 0 2 100 •Only 3% of the health facilities were overstocked (> 4 MoS). PNFP 46 87 1 2 4 8 2 4 53 100 •KIU Teaching Hospital in Bushenyi District reported on 19 bottles (5ml/ml) as quantity expired. Value of unit cost Ugx 173,717 Total 271 92 7 2 8 3 9 3 295 100

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty Ready to use Therapeutic feeds (RUTF) Ready to use Therapeutic feeds (RUTF) Ready to use Therapeutic feeds Level of Care Level of Care Level of Care Clinics 11 69 1 6 1 6 3 19 16 100 Clinics 1 0 1 HC 2s 167 72 32 14 13 6 19 8 231 100 HC 2s 7 1 8 Clinics 1 2 HC 3s 179 68 46 18 15 6 23 9 263 100 HC 3s 5 2 7 HC 2s 2 4,360 HC 4s 44 76 6 10 6 10 2 3 58 100 HC 4s 2 0 2 HC 3s 3 3,312 Gen Hosp 15 42 10 28 7 19 4 11 36 100 Gen Hosp 2 0 2 HC 4s 2 2,797 RRH 0 0 0 0 1 25 3 75 4 100 RRH 1 0 1 Total 8 10,471 NRH 0 0 0 0 1 100 0 0 1 100 Total 18 3 21 Total 416 68 95 16 44 7 54 9 609 100 Ownership Comments: Ready to use Therapeutic feeds (RUTF) Government 344 69 78 16 34 7 43 9 499 100 •68% and 16% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 13 93 0 0 1 7 0 0 14 100 •9% of the health facilities were overstocked (> 4 MoS). PNFP 59 62 17 18 9 9 11 12 96 100 •A total of 8 health facilities reported on 10,471 Sachets of (RUTF) as quantity expired.. Total 416 68 95 16 44 7 54 9 609 100

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Cotrimoxazole 960mg tablet Cotrimoxazole 960mg tablet Cotrimoxazole 960mg tablet Level of Care Level of Care Level of Care Clinics 7 18 9 24 9 24 13 34 38 100 Clinics 3 2 3 8 HC 2s 184 64 47 16 27 9 30 10 288 100 HC 2s 9 1 7 17 HC 2s 2 130 8,580 HC 3s 86 17 137 27 126 25 161 32 510 100 HC 3s 75 0 13 88 HC 3s 7 23,680 1,562,880 HC 4s 8 10 31 39 15 19 26 33 80 100 HC 4s 12 0 1 13 HC 4s 2 5,085 335,610 Gen Hosp 8 13 24 39 11 18 18 30 61 100 Gen Hosp 2 2 3 7 Gen Hosp 1 3 198 RRH 0 0 4 80 1 20 0 0 5 100 NRH 1 0 0 1 Total 12 28,898 1,907,268 NRH 0 0 0 0 0 0 2 100 2 100 Total 102 5 27 134 Total 293 30 252 26 189 19 250 25 984 100 Ownership Comments: Cotrimoxazole 960mg tablet Government 239 34 151 22 118 17 187 27 695 100 •30% and 26% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 18 27 25 38 12 18 11 17 66 100 •25% of the health facilities were overstocked (> 4 MoS). Govt owned HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 36 16 76 34 59 27 52 23 223 100 •A total of 12 health facilities reported on 28,898 tablets as quantity expired. Value of unit cost Ugx 1,907,268 Total 293 30 252 26 189 19 250 25 984 100

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Chlorhexidine Digluconate Gel 7.1% (equivalent to 4% chlorhexidine) Chlorhexidine Digluconate Gel 7.1% Chlorhexidine Digluconate Gel 7.1% Level of Care Level of Care Level of Care Clinics 12 63 5 26 1 5 1 5 19 100 HC 2s 2 2 0 4 HC 2s 11 2,041 16,532,100 HC 2s 147 47 92 29 59 19 16 5 314 100 HC 3s 11 0 1 12 HC 3s 11 2,075 16,807,500 HC 3s 121 35 104 30 79 23 39 11 343 100 HC 4s 3 0 0 3 HC 4s 1 3,072 24,883,200 HC 4s 32 52 13 21 8 13 9 15 62 100 Gen Hosp 3 0 3 6 Gen Hosp 2 12 97,200 Gen Hosp 13 33 11 28 6 15 9 23 39 100 Total 19 2 4 25 Total 25 7,200 58,320,000 RRH 1 25 2 50 0 0 1 25 4 100 NRH 0 0 0 0 1 100 0 0 1 100 Total 326 42 227 29 154 20 75 10 782 100 Ownership Comments: Chlorhexidine Digluconate Gel 7.1% (equivalent to 4% chlorhexidine) Government 238 38 189 30 142 23 62 10 631 100 •42% and 29% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 18 46 14 36 4 10 3 8 39 100 •10% of the health facilities were overstocked (> 4 MoS). Govt owned HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 70 63 24 21 8 7 10 9 112 100 •A total of 25 health facilities reported on 7,200 bottles of Chlorhexidine Digluconate Gel 7.1% as quantity expired. Total 326 42 227 29 154 20 75 10 782 100 Value of unit cost Ugx 58,320,000

April 2020 Facility Stock Status Report 4 of 10 Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty Ugx Bendrofulazide (Aprinox) 5mg Bendrofulazide (Aprinox) 5mg Bendrofulazide (Aprinox) 5mg Level of Care Level of Care Level of Care HC 3s 93 29 82 25 53 16 98 30 326 100 HC 3s 53 0 7 60 HC 3s 12 30243 967,776 HC 4s 16 29 10 18 14 26 15 27 55 100 HC 4s 8 0 0 8 HC 4s 1 2,022 64,704 Gen Hosp 8 17 13 28 10 21 16 34 47 100 Gen Hosp 3 2 3 8 Gen Hosp 1 6 192 RRH 1 17 3 50 0 0 2 33 6 100 RRH 2 0 0 2 Total 14 32,271 1,032,672 Total 118 27 108 25 77 18 131 30 434 100 Total 66 2 10 78

Ownership Comments: Bendrofulazide (Aprinox) 5mg Government 91 29 67 21 51 16 105 33 314 100 •27% and 25% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 0 0 5 36 5 36 4 29 14 100 •30% of the health facilities were overstocked (>4 MoS). Govt owned HC3s formed the larger part of the overstocked (>8 Mos) PNFP 27 26 36 34 21 20 22 21 106 100 •A total of 14 health facilities reported on 32,271 tablets of Bendrofulazide (5mg) as quantity expired. Total 118 27 108 25 77 18 131 30 434 100 Value of unit cost Ugx 1,032,672

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty ($) Artesunate 60mg Artesunate 60mg Artesunate 60mg Level of Care Level of Care Level of Care HC 3s 82 16 234 46 69 14 123 24 508 100 HC 3s 52 1 10 63 HC 3s 8 4,878 9,268 HC 4s 14 18 40 51 12 15 13 17 79 100 HC 4s 6 0 4 10 HC 4s 1 100 190 Gen Hosp 10 16 23 37 10 16 20 32 63 100 Gen Hosp 5 2 5 12 Gen Hosp 3 160 304 RRH 1 14 3 43 1 14 2 29 7 100 Total 63 3 19 85 Total 12 5,138 9,762 NRH 0 0 0 0 1 100 0 0 1 100 Total 107 16 300 46 93 14 158 24 658 100 Ownership Comments: Artesunate 60mg Government 81 17 224 46 70 14 113 23 488 100 •16% and 46% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 2 13 9 60 0 0 4 27 15 100 •24% of the health facilities were overstocked (> 4 MoS). Govt owned HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 24 16 67 43 23 15 41 27 155 100 •A total 12 health facilities reported on 5,138 tablets of Artesunate (60mg) as quantity expired. Total 107 16 300 46 93 14 158 24 658 100 Value of unit cost $ 9,762

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Nifedipine tablets 20mg Nifedipine tablets 20mg Nifedipine tablets 20mg Level of Care Level of Care Level of Care HC 3s 150 32 152 32 90 19 77 16 469 100 HC 3s 31 1 11 43 HC 3s 8 7,266 167,118 HC 4s 19 25 26 34 19 25 12 16 76 100 HC 4s 3 0 2 5 HC 4s 1 300 6,900 Gen Hosp 5 8 21 33 14 22 24 38 64 100 Gen Hosp 4 2 3 9 Gen Hosp 1 9 207 RRH 0 0 2 33 0 0 4 67 6 100 RRH 3 0 0 3 Total 10 7,575 174,225 NRH 0 0 0 0 0 0 2 100 2 100 NRH 2 0 0 2 Total 174 28 201 33 123 20 119 19 617 100 Total 43 3 16 62 Ownership Comments: Nifedipine tablets 20mg tablet Government 155 34 138 30 84 18 85 18 462 100 •28% and 33% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 1 6 11 61 2 11 4 22 18 100 •19% of the health facilities were overstocked (> 4 MoS). Govt owned HC3 facilities formed the larger part of the overstocked (> 8 Mos) PNFP 18 13 52 38 37 27 30 22 137 100 •A total 10 health facilities reported on 7,575 tablets as quantity expired. Total 174 28 201 33 123 20 119 19 617 100 Value of unit cost ugx 174,225.

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Captopril 25mg tablet Captopril 25mg tablet Captopril 25mg tablet Level of Care Level of Care Level of Care HC 4s 36 60 16 27 7 12 1 2 60 100 HC 4s 1 2022 188,046 Gen Hosp 10 19 23 44 7 14 12 23 52 100 Gen Hosp 3 1 6 10 Gen Hosp 2 81 7,533 RRH 0 0 2 40 2 40 1 20 5 100 Total 3 ##### ### 195,579 NRH 1 100 0 0 0 0 0 0 1 100 Total 3 1 6 10 Total 47 40 41 35 16 14 14 12 118 100 Ownership Comments: Captopril 25mg tablet Government 39 45 33 38 8 9 6 7 86 100 •40% and 35% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 1 33 0 0 1 33 1 33 3 100 •12% of the health facilities were overstocked (> 4 MoS). PNFP 7 24 8 28 7 24 7 24 29 100 •Three health facilities reported on 2,103 tablets as quantity expired. Total 47 40 41 35 16 14 14 12 118 100 Value of unit cost ugx 195,579

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Metformin 500mg Metformin 500mg Metformin 500mg Level of Care Level of Care Level of Care HC 3s 141 38 107 29 55 15 68 18 371 100 HC 3s 28 2 7 37 HC 3s 7 6,401 179,228 HC 4s 23 30 27 35 12 16 15 20 77 100 HC 4s 3 0 1 4 HC 4s 1 2,021 56,588 Gen Hosp 6 9 29 44 10 15 21 32 66 100 Gen Hosp 4 2 3 9 Gen Hosp 2 18 504 RRH 0 0 1 20 2 40 2 40 5 100 RRH 2 0 0 2 Total 10 8,440 236,320 NRH 2 100 0 0 0 0 0 0 2 100 Total 37 4 11 52 Total 172 33 164 32 79 15 106 20 521 100 Ownership Comments: Metformin 500mg Government 146 38 115 30 52 13 75 19 388 100 •33% and 32% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 0 0 10 50 3 15 7 35 20 100 •20% of the facilities were overstocked (> 4 MoS). Govt owned HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 26 23 39 35 24 21 24 21 113 100 •A total 10 health facilities reported on 8,440 tablets of Metformin (500mg) as quantity expired. Total 172 33 164 32 79 15 106 20 521 100 Value of unit cost ugx 236,320

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Glibenclamide 5mg tablet Glibenclamide 5mg tablet Glibenclamide 5mg tablet Level of Care Level of Care Level of Care HC 4s 14 22 20 31 12 19 19 29 65 100 HC 4s 10 0 2 12 HC 4s 3 608 11,552 Gen Hosp 15 26 14 25 13 23 15 26 57 100 Gen Hosp 3 2 4 9 Gen Hosp 2 141 2,679 RRH 0 0 4 100 0 0 0 0 4 100 Total 13 2 6 21 Total 5 749 14,231 NRH 1 100 0 0 0 0 0 0 1 100 Total 30 24 38 30 25 20 34 27 127 100 Ownership Comments: Glibenclamide 5mg tablet Government 21 23 28 31 19 21 23 25 91 100 •24% and 30% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 0 0 1 25 1 25 2 50 4 100 •27% of the health facilities were overstocked (> 4 MoS). PNFP 9 28 9 28 5 16 9 28 32 100 •Five health facilities reported on 749 tablets of Glibenclamide (5mg) as quantity expired. Total 30 24 38 30 25 20 34 27 127 100 Value of unit cost ugx 14,231

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Insulin short-acting Insulin short-acting Insulin short-acting Level of Care Level of Care Level of Care HC 4s 31 53 18 31 6 10 3 5 58 100 HC 4s 2 1 3 HC 4s 4 12 209,148 Gen Hosp 10 24 14 33 7 17 11 26 42 100 Gen Hosp 2 4 6 RRH 1 55 958,595 RRH 2 33 4 67 0 0 0 0 6 100 Total 4 5 9 Total 5 67 1,167,743 Total 43 41 36 34 13 12 14 13 106 100

Ownership Comments: Insulin short-acting Government 36 46 27 34 11 14 5 6 79 100 •41% and 34% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 0 0 2 67 1 33 0 0 3 100 •13% of the facilities were overstocked (> 4 MoS). PNFP 7 29 7 29 1 4 9 38 24 100 •Five health facilities reported on 67 bottles of Insulin short-acting as quantity expired. Total 43 41 36 34 13 12 14 13 106 100 Value of unit cost ugx 1,167,743

April 2020 Facility Stock Status Report 5 of 10 Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Cardiac Aspirin 75/80 mg Cardiac Aspirin 75/80 mg Cardiac Aspirin 75/80 mg Level of Care Level of Care Level of Care HC 4s 35 64 9 16 6 11 5 9 55 100 HC 4s 2 0 2 4 HC 4s 3 12,903 619,344 Gen Hosp 11 20 20 36 11 20 14 25 56 100 Gen Hosp 3 2 2 7 Gen Hosp 1 3 144 RRH 2 29 4 57 1 14 0 0 7 100 Total 5 4 11 Total 4 12,906 619,488 NRH 1 100 0 0 0 0 0 0 1 100 Total 49 41 33 28 18 15 19 16 119 100 Ownership Comments: Cardiac Aspirin 75/80 mg Government 42 52 20 25 10 12 9 11 81 100 •41% and 28% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 0 0 4 67 0 0 2 33 6 100 •16% of the health facilities were overstocked (> 4 MoS). PNFP 7 22 9 28 8 25 8 25 32 100 •Four health facilities reported on 12,906 tablets of Cardiac Aspirin (75/80 mg) as quantity expired. Total 49 41 33 28 18 15 19 16 119 100 Value of unit cost ugx 619,488

ARV BASKET

Note: Stock Status data for new regimes being used under HIV treatment optimization can be from the WAOs/RAAS reports

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/ 600mg TDF/3TC/EFV 300mg/300mg/ 600mg TDF/3TC/EFV 300mg/300mg/ 600mg Level of Care Level of Care Level of Care Clinics 9 32 8 29 8 29 3 11 28 100 Clinics 1 0 1 2 HC 2s 162 60 59 22 22 8 26 10 269 100 HC 2s 5 1 3 9 HC 2s 7 6,759 4,900,275 HC 3s 94 18 225 42 110 20 109 20 538 100 HC 3s 47 0 7 54 HC 3s 8 6,379 4,624,775 HC 4s 14 17 40 47 19 22 12 14 85 100 HC 4s 6 0 1 7 HC 4s 3 5,062 3,669,950 Gen Hosp 7 12 20 33 17 28 16 27 60 100 Gen Hosp 4 0 3 7 Gen Hosp 2 21 15,225 RRH 2 33 1 17 1 17 2 33 6 100 Total 63 1 15 79 Total 20 18,221 13,210,225 NRH 0 0 0 0 0 0 1 100 1 100 Total 288 29 353 36 177 18 169 17 987 100 Ownership Comments: TDF/3TC/EFV 300mg/300mg/ 600mg Government 244 33 255 35 109 15 129 18 737 100 •29% and 36% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 14 45 10 32 6 19 1 3 31 100 •17% of the health facilities were overstocked (> 4 MoS). Govt owned HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 30 14 88 40 62 28 39 18 219 100 •A total of 20 health facilities reported on 18,221 tablets of TDF/3TC/EFV (300mg/300mg/ 600mg) as quantity expired. Total 288 29 353 36 177 18 169 17 987 100 Value of unit cost ugx 13,210,225. This item is being phased out, cut off date for a complete phase-out is December 2020.

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) AZT/3TC/NVP 300mg/150mg/200mg AZT/3TC/NVP 300mg/150mg/200mg AZT/3TC/NVP 300mg/150mg/200mg Level of Care Level of Care Level of Care Clinics 11 52 1 5 3 14 6 29 21 100 Clinics 0 3 3 Clinics 1 12 7,464 HC 2s 168 82 14 7 8 4 15 7 205 100 HC 2s 6 1 7 HC 2s 3 16 9,952 HC 3s 75 23 71 22 48 15 130 40 324 100 HC 3s 77 7 84 HC 3s 12 4,154 2,583,788 HC 4s 8 16 11 22 7 14 24 48 50 100 HC 4s 15 2 17 HC 4s 3 5,035 3,131,770 Gen Hosp 3 7 12 29 8 20 18 44 41 100 Gen Hosp 11 2 13 Gen Hosp 4 99 61,578 RRH 0 0 0 0 0 0 3 100 3 100 RRH 2 0 2 RRH 1 2 1,244 NRH 1 50 0 0 0 0 1 50 2 100 NRH 1 0 1 Total 24 9318 5,795,796 Total 266 41 109 17 74 12 197 31 646 100 Total 112 15 127 Ownership Comments: AZT/3TC/NVP 300mg/150mg/200mg Government 196 40 82 17 52 11 165 33 495 100 •41% and 17% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 15 71 1 5 2 10 3 14 21 100 •31% of the health facilities were overstocked (> 4 MoS). Govt owned HC3s & HC4s formed the larger part of the overstocked (> 8 Mos) PNFP 55 42 26 20 20 15 29 22 130 100 •A total of 24 facilities reported on 9,318 tablets as quantity expired. Total 266 41 109 17 74 12 197 31 646 100 Value of unit cost ugx 5,795,796. This item is being phased out, cut off date for a complete phase-out is December 2020.

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Atazanavir/ritonavir(ATV/r)300/100mg tablet Atazanavir/ritonavir(ATV/r)300/100mg table Atazanavir/ritonavir(ATV/r) Level of Care Level of Care Level of Care HC 3s 136 33 174 42 47 11 61 15 418 100 HC 3s 25 1 6 32 HC 3s 11 8,106 13,553,232 HC 4s 28 35 33 41 8 10 11 14 80 100 HC 4s 2 0 0 2 HC 4s 2 5,054 8,450,288 Gen Hosp 11 20 31 55 9 16 5 9 56 100 Gen Hosp 3 0 0 3 Gen Hosp 2 14 23,408 RRH 4 67 2 33 0 0 0 0 6 100 NRH 1 0 0 1 Total 15 13,174 22,026,928 NRH 0 0 0 0 0 0 1 100 1 100 Total 31 1 6 38 - Total 179 32 240 43 64 11 78 14 561 100 Ownership Comments: Atazanavir/ritonavir(ATV/r)300/100mg tablet Government 158 36 172 40 44 10 60 14 434 100 •32% and 43% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 0 0 4 67 1 17 1 17 6 100 •14% of the health facilities were overstocked (> 4 MoS). Govt owned HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 21 17 64 53 19 16 17 14 121 100 •A total of 15 facilities reported on 13,174 tablets as quantity expired. Total 179 32 240 43 64 11 78 14 561 100 Value of unit cost ugx 22,026,928

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Tenofovir/Lamivudine (TDF/3TC) 300mg/300mg Tenofovir/Lamivudine (TDF/3TC) 300mg/300mg TDF/3TC 300mg/300mg Level of Care Level of Care Level of Care HC 3s 57 14 133 32 73 18 148 36 411 100 HC 3s 90 1 11 102 HC 3s 25 21,024 14,611,680 HC 4s 10 14 21 30 8 11 32 45 71 100 HC 4s 13 0 2 15 HC 4s 4 7,713 5,360,535 Gen Hosp 6 12 21 41 7 14 17 33 51 100 Gen Hosp 6 0 2 8 Gen Hosp 5 394 273,830 RRH 1 20 2 40 0 0 2 40 5 100 RRH 2 0 0 2 Total 34 29,131 20,246,045 NRH 0 0 1 50 0 0 1 50 2 100 Total 111 1 15 127 Total 74 14 178 33 88 16 200 37 540 100 Ownership Comments: Tenofovir/Lamivudine (TDF/3TC) 300mg/300mg Government 50 12 123 30 68 17 171 42 412 100 •14% and 33% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 2 33 2 33 0 0 2 33 6 100 •37% of the health facilities were overstocked (> 4 MoS). Govt owned HC3s & HC4s formed the larger part of the overstocked (> 8 Mos) PNFP 22 18 53 43 20 16 27 22 122 100 •A total of 34 health facilities reported on 29,131 tablets as quantity expired. Total 74 14 178 33 88 16 200 37 540 100 Value of unit cost ugx 20,246,045

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) TDF/3TC/DTG 300mg/300mg/50mg (TLD) TDF/3TC/DTG 300mg/300mg/50mg (TLD) TDF/3TC/DTG 300mg/300mg/50mg Level of Care Level of Care Level of Care HC 3s 34 7 231 44 104 20 155 30 524 100 HC 3s 52 4 56 HC 3s 7 4,386 4,552,668 HC 4s 5 6 32 40 25 31 19 24 81 100 HC 4s 7 0 7 HC 4s 2 4,842 5,025,996 Gen Hosp 2 4 26 46 11 20 17 30 56 100 Gen Hosp 7 1 8 Gen Hosp 2 211 219,018 RRH 0 0 2 33 3 50 1 17 6 100 Total 66 5 71 Total 11 9,439 9,797,682 NRH 0 0 0 0 0 0 2 100 2 100 Total 41 6 291 44 143 21 194 29 669 100 Ownership Comments: TDF/3TC/DTG 300mg/300mg/50mg (TLD) Government 32 6 197 39 102 20 175 35 506 100 •6% and 44% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 0 0 7 88 1 13 0 0 8 100 •29% of the health facilities were overstocked (> 4 MoS). Govt owned HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 9 6 87 56 40 26 19 12 155 100 •A total of 11 health facilities reported on 9,439 tablets as quantity expired. Total 41 6 291 44 143 21 194 29 669 100 Value of unit cost ugx 9,797,682

April 2020 Facility Stock Status Report 6 of 10 Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) TLE 300mg/300mg/600mg TLE 300mg/300mg/600mg TLE 300mg/300mg/600mg Level of Care Level of Care Level of Care Clinics 11 92 1 8 0 0 0 0 12 100 HC 2s 1 1188 861,300 HC 2s 177 96 4 2 2 1 1 1 184 100 HC 2s 1 0 1 HC 3s 5 1,568 1,136,800 HC 3s 221 86 15 6 11 4 9 4 256 100 HC 3s 4 0 4 Gen Hosp 1 7 5,075 HC 4s 43 83 3 6 3 6 3 6 52 100 HC 4s 1 1 2 Total 7 2,763 2,003,175 Gen Hosp 22 85 0 0 1 4 3 12 26 100 Gen Hosp 1 0 1 RRH 3 75 1 25 0 0 0 0 4 100 Total 7 1 8 Total 477 89 24 5 17 3 16 3 534 100 Ownership Comments: TLE 300mg/300mg/600mg Government 387 89 19 4 14 3 13 3 433 100 •89% and 5% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 15 94 1 6 0 0 0 0 16 100 •Only 3% of the health facilities were overstocked (> 4 MoS). PNFP 75 88 4 5 3 4 3 4 85 100 •A total of 7 health facilities reported on 2,763 tablets as quantity expired. Total 477 89 24 5 17 3 16 3 534 100 Value of unit cost ugx 2,003,175

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Abacavir/Lamivudine (ABC/3TC) 120mg/60mg (Paediatric) Abacavir/Lamivudine (ABC/3TC) 120mg/60mg (ABC/3TC) 120mg/60mg Level of Care Level of Care Level of Care HC 3s 77 19 122 30 81 20 124 31 404 100 HC 3s 46 4 50 HC 3s 16 4,974 1,999,548 HC 4s 8 11 26 37 14 20 22 31 70 100 HC 4s 7 0 7 HC 4s 2 5,033 2,023,266 Gen Hosp 6 12 17 35 14 29 12 25 49 100 Gen Hosp 4 1 5 Gen Hosp 2 77 30,954 RRH 0 0 2 50 0 0 2 50 4 100 RRH 2 0 2 RRH 1 66 26,532 NRH 0 0 1 100 0 0 0 0 1 100 Total 59 5 64 Total 21 10,150 4,080,300 Total 91 17 168 32 109 21 160 30 528 100 Ownership Comments: Abacavir/Lamivudine (ABC/3TC) 120mg/60mg) Government 70 17 113 28 78 19 141 35 402 100 •17% and 32% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 0 0 2 67 1 33 0 0 3 100 •30% of the health facilities were overstocked (> 4 MoS). Govt owned HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 21 17 53 43 30 24 19 15 123 100 •A total of 21 health facilities reported on 10,150 tablets of Abacavir/Lamivudine (120mg/60mg) as quantity expired. Total 91 17 168 32 109 21 160 30 528 100 Value of unit cost ugx 4,080,300

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per capsule No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Lopinavir/ritonavir 40mg/10mg pellets in capsules Lopinavir/ritonavir 40mg/10mg pellets in capsules Lopinavir/ritonavir 40mg/10mg Level of Care Level of Care Level of Care HC 3s 139 47 90 30 29 10 41 14 299 100 HC 3s 16 3 19 HC 3s 18 4,180 2,633,400 HC 4s 24 47 19 37 5 10 3 6 51 100 HC 4s 1 2 3 HC 4s 7 5,112 3,220,560 Gen Hosp 14 40 10 29 6 17 5 14 35 100 Gen Hosp 0 3 3 Gen Hosp 3 20 12,600 RRH 1 20 3 60 1 20 0 0 5 100 Total 17 8 25 Total 28 9,312 5,866,560 NRH 0 0 0 0 1 100 0 0 1 100 Total 178 46 122 31 42 11 49 13 391 100 Ownership Comments: Lopinavir/ritonavir 40mg/10mg pellets in capsules Government 151 50 87 29 29 10 37 12 304 100 •46% and 31% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 0 0 1 50 1 50 0 0 2 100 •13% of the health facilities were overstocked (> 4 MoS). PNFP 27 32 34 40 12 14 12 14 85 100 •A total of 28 health facilities reported on 9,312 capsules as quantity expired. Total 178 46 122 31 42 11 49 13 391 100 Value of unit cost ugx 5,866,560

RMNCAH BASKET

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Depot medroxy progesterone acetate (DMPA) Depot medroxy progesterone acetate (DMPA) Depot medroxy progesterone acetate Level of Care Level of Care Level of Care Clinics 10 31 2 6 6 19 14 44 32 100 Clinics 0 6 3 9 HC 2s 250 39 107 17 76 12 203 32 636 100 HC 2s 115 6 15 136 HC 2s 18 8,940 9,556,860 HC 3s 168 40 87 21 59 14 107 25 421 100 HC 3s 40 2 11 53 HC 3s 16 17,774 19,000,406 HC 4s 29 49 9 15 9 15 12 20 59 100 HC 4s 8 0 0 8 HC 4s 3 3,257 3,481,733 Gen Hosp 11 31 11 31 3 9 10 29 35 100 Gen Hosp 3 2 2 7 Gen Hosp 2 234 250,146 RRH 3 75 0 0 0 0 1 25 4 100 RRH 1 0 0 1 Total 39 30,205 32,289,145 Total 471 40 216 18 153 13 347 29 1187 100 Total 167 16 31 214

Ownership Comments: Depot medroxy progesterone acetate (DMPA) Government 396 43 157 17 108 12 269 29 930 100 •40% and 18% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 22 26 26 31 13 16 23 27 84 100 •29% of the health facilities were overstocked (> 4 MoS). Govt owned HC2 & HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 53 31 33 19 32 19 55 32 173 100 •A total of 39 health facilities reported on 30,205 (150 mg/ml) injection as quantity expired. Total 471 40 216 18 153 13 347 29 1187 100 Value of unit cost ugx 32,289,145

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per capsule No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Amoxicillin 250 mg capsule Amoxicillin 250 mg capsule Amoxicillin 250 mg capsule Level of Care Level of Care Level of Care Clinics 7 13 27 50 10 19 10 19 54 100 Clinics 2 2 1 5 HC 2s 20 12,490 661,970 HC 2s 311 32 400 42 126 13 122 13 959 100 HC 2s 46 3 15 64 HC 3s 9 63,987 3,391,311 HC 3s 107 18 300 49 99 16 101 17 607 100 HC 3s 40 1 6 47 HC 4s 1 3,072 162,816 HC 4s 22 24 42 47 13 14 13 14 90 100 HC 4s 5 0 2 7 Gen Hosp 1 9 477 Gen Hosp 3 5 25 41 18 30 15 25 61 100 Gen Hosp 5 1 4 10 Total 31 79,558 4,216,574 RRH 0 0 2 33 0 0 4 67 6 100 RRH 2 0 0 2 NRH 1 50 0 0 0 0 1 50 2 100 NRH 1 0 0 1 Total 451 25 796 45 266 15 266 15 1779 100 Total 101 7 28 136 Ownership Comments: Amoxicillin 250 mg capsule Government 403 30 560 42 177 13 191 14 1331 100 •25% and 45% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 14 9 92 62 26 17 17 11 149 100 •15% of the health facilities were overstocked (> 4 MoS). PNFP 34 11 144 48 63 21 58 19 299 100 •A total of 31 health facilities reported on 79,558 capsules as quantity expired. Total 451 25 796 45 266 15 266 15 1779 100 Value of unit cost ugx 4,216,574

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Sulfadoxine/ Pyrimethamine tablet Sulfadoxine/ Pyrimethamine tablet Sulfadoxine/ Pyrimethamine tablet Level of Care Level of Care Level of Care Clinics 13 28 17 36 5 11 12 26 47 100 Clinics 1 4 3 8 Clinics 3 257 25,957 HC 2s 161 24 105 16 80 12 316 48 662 100 HC 2s 240 5 16 261 HC 2s 30 19,570 1,976,570 HC 3s 87 20 112 26 88 20 153 35 440 100 HC 3s 85 1 19 105 HC 3s 9 25,425 2,567,925 HC 4s 13 19 18 26 15 22 23 33 69 100 HC 4s 13 0 2 15 HC 4s 3 5,265 531,765 Gen Hosp 9 17 16 31 13 25 14 27 52 100 Gen Hosp 3 1 2 6 Gen Hosp 2 99 9,999 RRH 2 33 0 0 3 50 1 17 6 100 RRH 1 0 0 1 Total 47 50,616 5,112,216 NRH 0 0 0 0 0 0 1 100 1 100 NRH 1 0 0 1 Total 285 22 268 21 204 16 520 41 1277 100 Total 344 11 42 397 Ownership Comments: Sulfadoxine/ Pyrimethamine tablet Government 196 22 125 14 150 17 434 48 905 100 •22% and 21% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 26 22 62 52 14 12 18 15 120 100 •41% of the health facilities were overstocked (>4 MoS). Govt owned HC2 & HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 63 25 81 32 40 16 68 27 252 100 •A total 47 health facilities reported on 50,616 tablets as quantity expired, the majority of facilities wih expiries being HC2s and HC3s. Total 285 22 268 21 204 16 520 41 1277 100 Value of unit cost ugx 5,112,216

April 2020 Facility Stock Status Report 7 of 10 Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) ORS Sachets with zinc tablet ORS Sachets with zinc tablet ORS Sachets with zinc tablet Level of Care Level of Care Level of Care Clinics 11 31 10 29 5 14 9 26 35 100 Clinics 0 3 2 5 HC 2s 171 19 323 37 161 18 225 26 880 100 HC 2s 111 3 17 131 HC 2s 20 10,031 14,444,640 HC 3s 80 14 213 38 110 19 165 29 568 100 HC 3s 61 1 11 73 HC 3s 7 10,237 14,741,280 HC 4s 13 17 29 38 14 18 21 27 77 100 HC 4s 7 0 1 8 HC 4s 1 3,082 4,438,080 Gen Hosp 8 15 18 33 5 9 24 44 55 100 Gen Hosp 8 2 7 17 Gen Hosp 1 7 10,080 RRH 0 0 1 17 0 0 5 83 6 100 RRH 2 0 0 2 Total 29 23,357 33,634,080 NRH 0 0 0 0 0 0 2 100 2 100 Total 189 9 38 236 Total 283 17 594 37 295 18 451 28 1623 100 Ownership Comments: ORS Sachets with zinc tablet Government 215 17 453 36 231 18 359 29 1258 100 •17% and 37% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 19 17 56 50 20 18 17 15 112 100 •28% of the health facilities were overstocked (> 4 MoS). Govt owned HC2 & HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 49 19 85 34 44 17 75 30 253 100 •A total of 29 health facilities reported on 23,357 ORS Sachets with zinc tablet as quantity expired. Total 283 17 594 37 295 18 451 28 1623 100 Value of unit cost ugx 33,634,080

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Measles-Rubella Vaccine Measles Measles-Rubella Vaccine Level of Care Level of Care Level of Care Clinics 13 77 3 18 1 6 0 0 17 100 HC 2s 102 2 13 117 HC 2s 18 8570 218,766,390 HC 2s 167 26 155 24 123 19 192 30 637 100 HC 3s 90 1 20 111 HC 3s 9 7,152 182,569,104 HC 3s 50 10 168 35 91 19 175 36 484 100 HC 4s 14 0 4 18 HC 4s 2 2,115 53,989,605 HC 4s 8 11 26 36 15 21 24 33 73 100 Gen Hosp 5 0 3 8 Gen Hosp 1 9 229,743 Gen Hosp 1 2 14 34 15 37 11 27 41 100 RRH 1 0 0 1 Total 30 17,846 455,554,842 RRH 0 0 2 67 0 0 1 33 3 100 Total 212 3 40 255 Total 239 19 368 29 245 20 403 32 1255 100

Ownership Comments: Measles-Rubella Vaccine Government 171 18 283 29 190 19 335 34 979 100 •19% and 29% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 27 52 12 23 10 19 3 6 52 100 •32% of the health facilities were overstocked (> 4 MoS). Govt owned HC2 & HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 41 18 73 33 45 20 65 29 224 100 •A total of 30 health facilities reported on 17,846 bottles of Measles-Rubella Vaccine (0.5ml/dose) injection as quantity expired. Total 239 19 368 29 245 20 403 32 1255 100 Value of unit cost ugx 455,554,842

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Misoprostol 200mg Tablet Misoprostol 200mg Tablet Misoprostol 200mg Tablet Level of Care Level of Care Level of Care Clinics 10 29 10 29 8 24 6 18 34 100 Clinics 0 1 1 2 HC 2s 31 10,118 4,330,504 HC 2s 108 34 56 18 47 15 108 34 319 100 HC 2s 73 1 6 80 HC 3s 43 11,872 5,081,216 HC 3s 63 18 84 23 88 24 125 35 360 100 HC 3s 69 0 11 80 HC 4s 3 2,216 948,448 HC 4s 14 19 25 33 21 28 15 20 75 100 HC 4s 7 0 1 8 Gen Hosp 4 3,305 1,414,540 Gen Hosp 6 10 23 38 13 22 18 30 60 100 Gen Hosp 5 1 5 11 NRH 1 56,100 24,010,800 RRH 0 0 4 67 1 17 1 17 6 100 RRH 1 0 0 1 Total 82 83,611 35,785,508 NRH 0 0 0 0 0 0 1 100 1 100 Total 155 3 24 182 Total 201 24 202 24 178 21 274 32 855 100 Ownership Comments: Misoprostol 200mg Tablet Government 141 23 133 22 115 19 229 37 618 100 •24% of the health facilities were stocked-out (0 MoS). PFP 14 18 29 38 21 28 12 16 76 100 •32% of the facilities were overstocked (> 4 MoS). Govt owned HC2 & HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 46 29 40 25 42 26 33 21 161 100 •A total of 82 facilities reported on 83,611 (200mg) tablets as quntity expired, the majority being HC2s and HC3s. Total 201 24 202 24 178 21 274 32 855 100 Value of unit cost ugx 35,785,508

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Amoxicillin dispersible 250mg tablet Amoxicillin dispersible 250mg tablet Amoxicillin dispersible 250mg tablet Level of Care Level of Care Level of Care Clinics 8 35 8 35 4 17 3 13 23 100 Clinics 0 1 1 2 HC 2s 9 4,688 337,536 HC 2s 228 35 208 32 105 16 111 17 652 100 HC 2s 40 3 6 49 HC 3s 9 11,018 793,296 HC 3s 107 21 200 40 78 16 117 23 502 100 HC 3s 41 1 6 48 Gen Hosp 2 809 58,248 HC 4s 25 33 33 44 7 9 10 13 75 100 HC 4s 8 0 0 8 Total 20 16,515 1,189,080 Gen Hosp 10 25 12 30 8 20 10 25 40 100 Gen Hosp 6 0 4 10 RRH 1 14 2 29 1 14 3 43 7 100 RRH 2 0 0 2 Total 379 29 463 36 203 16 254 20 1299 100 Total 97 5 17 119

Ownership Comments: Amoxicillin dispersible 250mg tablet Government 315 30 379 36 154 15 214 20 1062 100 •29% and 36% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 13 22 29 48 11 18 7 12 60 100 •20% of the facilities were overstocked (> 4 MoS). Govt owned HC2 & HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 51 29 55 31 38 22 33 19 177 100 •A total of 20 health facilities reported on 16,515 tablets as quantity expired, the majority being HC2s and HC3s. Total 379 29 463 36 203 16 254 20 1299 100 Value of unit cost ugx 1,189,080

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per injection No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Ceftriaxone 1g Injection Ceftriaxone 1g Injection Ceftriaxone 1g Injection Level of Care Level of Care Level of Care HC 3s 126 24 262 50 69 13 71 13 528 100 HC 3s 26 0 9 35 HC 3s 7 4,370 6,686,100 HC 4s 26 33 38 49 7 9 7 9 78 100 HC 4s 1 0 1 2 HC 4s 1 3,070 4,697,100 Gen Hosp 8 12 32 49 13 20 13 20 66 100 Gen Hosp 1 1 3 5 Gen Hosp 1 7 10,710 RRH 1 17 4 67 0 0 1 17 6 100 Total 28 1 13 42 Total 9 7,447 11,393,910 NRH 0 0 1 100 0 0 0 0 1 100 Total 161 24 337 50 89 13 92 14 679 100 Ownership Comments: Ceftriaxone 1g Injection Government 136 28 236 48 60 12 61 12 493 100 •24% and 50% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 2 11 15 79 1 5 1 5 19 100 •14% of the health facilities were overstocked (> 4 MoS). Govt owned HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 23 14 86 52 28 17 30 18 167 100 •A total of 9 health facilities reported on 7,447 (1g) injection as quantity expired. Total 161 24 337 50 89 13 92 14 679 100 Value of unit cost ugx 11,393,910

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per injection No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Oxytocin Injection Oxytocin Injection Oxytocin Injection Level of Care Level of Care Level of Care HC 3s 166 37 98 22 72 16 109 25 445 100 HC 3s 55 0 12 67 HC 3s 8 2,967 1,513,170 HC 4s 32 46 28 41 3 4 6 9 69 100 HC 4s 1 0 0 1 HC 4s 2 3,110 1,586,100 Gen Hosp 11 19 26 44 13 22 9 15 59 100 Gen Hosp 3 1 2 6 Gen Hosp 1 12 6,120 RRH 1 14 2 29 2 29 2 29 7 100 RRH 1 0 0 1 Total 11 6,089 3,105,390 NRH 0 0 0 0 1 100 0 0 1 100 Total 60 1 14 75 Total 210 36 154 27 91 16 126 22 581 100 Ownership Comments: Oxytocin Injection Government 180 43 80 19 62 15 97 23 419 100 •36% and 27% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 1 7 10 67 3 20 1 7 15 100 •22% of the health facilities were overstocked (> 4 MoS). Govt owned HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 29 20 64 44 26 18 28 19 147 100 •A total of 11 health facilities reported on 6,089 bottles of Oxytocin Injection as quantity expired. Total 210 36 154 27 91 16 126 22 581 100 Value of unit cost ugx 3,105,390

April 2020 Facility Stock Status Report 8 of 10 Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per kit No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Mama Kit Mama Kit Mama Kit Level of Care Level of Care Level of Care Clinics 9 53 5 29 2 12 1 6 17 100 Clinics 0 0 1 1 HC 2s 3 185 3,995,260 HC 2s 195 69 43 15 21 7 23 8 282 100 HC 2s 12 1 2 15 HC 3s 6 2,139 46,193,844 HC 3s 163 35 155 33 84 18 67 14 469 100 HC 3s 29 0 1 30 HC 4s 2 2,826 61,030,296 HC 4s 28 39 20 28 12 17 12 17 72 100 HC 4s 5 0 0 5 Gen Hosp 1 1 21,596 Gen Hosp 14 33 16 38 8 19 4 10 42 100 RRH 1 0 0 1 Total 12 5151 111,240,996 RRH 2 40 1 20 1 20 1 20 5 100 Total 47 1 4 52 NRH 1 100 0 0 0 0 0 0 1 100 Total 412 46 240 27 128 14 108 12 888 100 Ownership Comments: Mama Kit Government 311 44 198 28 104 15 95 13 708 100 •46% of the health facilities were stocked-out (0 MoS) PFP 15 34 24 55 4 9 1 2 44 100 •12% of the health facilities were overstocked (> 4 MoS). Govt owned HC2 & HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 86 63 18 13 20 15 12 9 136 100 •A total 12 health facilities reported on 5,151 packs of mama kit as quantity expired. Total 412 46 240 27 128 14 108 12 888 100 Value of unit cost ugx 111,240,996

LAB BASKET

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per test No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Determine HIV 1 & 2 screening test Determine HIV 1 & 2 screening test Determine HIV 1 & 2 screening test Level of Care Level of Care Level of Care Clinics 10 18 20 36 6 11 19 35 55 100 Clinics 0 6 7 13 Clinics 6 3,196 9,949,148 HC 2s 237 40 145 25 88 15 117 20 587 100 HC 2s 58 11 9 78 HC 2s 122 23,262 72,414,606 HC 3s 87 15 158 28 127 22 203 35 575 100 HC 3s 86 2 20 108 HC 3s 157 142,542 443,733,246 HC 4s 7 9 22 28 26 33 25 31 80 100 HC 4s 11 0 2 13 HC 4s 24 36,902 114,875,926 Gen Hosp 6 11 12 21 9 16 30 53 57 100 Gen Hosp 8 2 9 19 Gen Hosp 8 4,005 12,467,565 RRH 1 20 2 40 0 0 2 40 5 100 Total 163 21 47 231 RRH 2 3,400 10,584,200 NRH 0 0 0 0 0 0 1 100 1 100 Total 319 213,307 664,024,691 Total 348 26 359 26 256 19 397 29 1360 100 Ownership Comments: Determine HIV 1 & 2 screening test Government 286 30 241 25 162 17 280 29 969 100 •26% of the health facilities were stocked-out (0 MoS) PFP 20 15 52 39 28 21 34 25 134 100 •29% of the health facilities were overstocked (> 4 MoS). Govt owned HC2 & HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 42 16 66 26 66 26 83 32 257 100 •A total of 319 health facilities reported on 213,307 Determine HIV screening tests as quantity expired. Total 348 26 359 26 256 19 397 29 1360 100 Value of unit cost ugx 664,024,691

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per test No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Stat -pack HIV Confirmatory rapid tests Stat -pack HIV Confirmatory rapid tests Stat -pack HIV Confirmatory rapid tests Level of Care Level of Care Level of Care Clinics 12 39 5 16 4 13 10 32 31 100 Clinics 0 4 4 8 Clinics 1 21 77,637 HC 2s 191 57 33 10 30 9 81 24 335 100 HC 2s 43 8 5 56 HC 2s 19 3,226 11,926,522 HC 3s 92 26 66 18 59 16 143 40 360 100 HC 3s 80 2 18 100 HC 3s 12 9,049 33,454,153 HC 4s 11 20 11 20 12 21 22 39 56 100 HC 4s 13 0 3 16 HC 4s 4 7,645 28,263,565 Gen Hosp 6 15 5 12 8 20 22 54 41 100 Gen Hosp 7 2 4 13 Gen Hosp 2 10 36,970 RRH 2 40 0 0 1 20 2 40 5 100 RRH 1 0 0 1 Total 38 19,951 73,758,847 NRH 0 0 1 100 0 0 0 0 1 100 Total 144 16 34 194 Total 314 38 121 15 114 14 280 34 829 100 Ownership Comments: Stat -pack HIV Confirmatory rapid tests Government 252 40 83 13 84 14 205 33 624 100 •38% of the health facilities were stocked-out (0 MoS) PFP 16 29 12 21 8 14 20 36 56 100 •34% of the facilities were overstocked (> 4 MoS). Govt owned HC2 & HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 46 31 26 17 22 15 55 37 149 100 •A total of 38 health facilities reported on 19,951 Stat -pack HIV Confirmatory rapid tests as quantity expired. Total 314 38 121 15 114 14 280 34 829 100 Value of unit cost ugx 73,758,847

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per test No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) SD Bioline test-Tie Breaker SD Bioline test-Tie Breaker SD Bioline test-Tie Breaker Level of Care Level of Care Level of Care Clinics 9 69 1 8 2 15 1 8 13 100 Clinics 0 0 1 1 HC 2s 209 78 11 4 15 6 32 12 267 100 HC 2s 16 4 2 22 HC 2s 13 313 981,255 HC 3s 135 58 23 10 22 9 53 23 233 100 HC 3s 26 1 6 33 HC 3s 36 3,500 10,972,500 HC 4s 14 40 3 9 8 23 10 29 35 100 HC 4s 7 0 2 9 HC 4s 5 2,198 6,890,730 Gen Hosp 14 48 4 14 2 7 9 31 29 100 Gen Hosp 1 1 5 7 Gen Hosp 4 360 1,128,600 RRH 2 67 0 0 0 0 1 33 3 100 RRH 1 0 0 1 RRH 1 32 100,320 Total 383 66 42 7 49 8 106 18 580 100 Total 51 6 16 73 Total 59 6,403 20,073,405

Ownership Comments: SD Bioline test-Tie Breaker Government 306 70 29 7 36 8 69 16 440 100 •66% of the health facilities were stocked-out (0 MoS) PFP 13 45 2 7 5 17 9 31 29 100 •18% of the health facilities were overstocked (> 4 MoS). Govt owned HC2 & HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 64 58 11 10 8 7 28 25 111 100 •A total of 59 health facilities reported on 6,403 SD Bioline test-Tie Breaker as quantity expired. Total 383 66 42 7 49 8 106 18 580 100 Value of unit cost ugx 20,073,405

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) CD4 reagent CD4 reagent CD4 reagent Level of Care Level of Care Level of Care HC 4s 31 69 7 16 1 2 6 13 45 100 HC 4s 3 3 HC 4s 4 839 2,630,265 Gen Hosp 17 65 4 15 1 4 4 15 26 100 Gen Hosp 1 1 Gen Hosp 3 236 739,860 RRH 3 60 2 40 0 0 0 0 5 100 Total 4 4 Total 7 1,075 3,370,125 Total 51 67 13 17 2 3 10 13 76 100

Ownership Comments: CD4 reagent Government 45 73 10 16 0 0 7 11 62 100 •67% of the health facilities were stocked-out (0 MoS) PNFP 6 43 3 21 2 14 3 21 14 100 •13% of the health facilities were overstocked (> 4 MoS). Total 51 67 13 17 2 3 10 13 76 100 •A total of 7 health facilities reported on 1,075 CD4 reagents as quantity expired. Value of unit cost ugx 3,370,125

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per mRDT test No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty ($) Malaria Rapid Diagnostic tests Malaria Rapid Diagnostic tests Malaria Rapid Diagnostic tests Level of Care Level of Care Level of Care Clinics 9 20 15 33 7 15 15 33 46 100 Clinics 3 4 4 11 Clinics 3 96 28 HC 2s 96 10 295 32 140 15 394 43 925 100 HC 2s 199 9 26 234 HC 2s 46 49,193 14,168 HC 3s 58 10 187 31 104 17 251 42 600 100 HC 3s 122 0 20 142 HC 3s 19 39,037 11,243 HC 4s 10 11 37 42 13 15 28 32 88 100 HC 4s 15 0 2 17 HC 4s 2 3,142 905 Gen Hosp 3 6 16 30 11 21 23 43 53 100 Gen Hosp 3 1 6 10 Gen Hosp 1 11 3 RRH 1 20 2 40 0 0 2 40 5 100 RRH 2 0 0 2 Total 71 91,479 26,346 NRH 0 0 0 0 0 0 1 100 1 100 NRH 1 0 0 1 Total 177 10 552 32 275 16 714 42 1718 100 Total 345 14 58 417 Ownership Comments: Malaria Rapid Diagnostic tests Government 139 11 403 31 196 15 567 43 1305 100 •10% of the health facilities were stocked-out (0 MoS) PFP 13 11 62 51 21 17 25 21 121 100 •42% of the health facilities were overstocked (> 4 MoS). Govt owned HC2 & HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 25 9 87 30 58 20 122 42 292 100 •A total of 71 health facilities reported on 91,479 mRDT test kits as quantity expired, the majority with expiries being HC2s and HC3s. Total 177 10 552 32 275 16 714 42 1718 100 Value of the cost for the packs being $ 26,346

April 2020 Facility Stock Status Report 9 of 10 Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) GeneXepert Catridges GeneXepert Catridges GeneXepert Catridges Level of Care Level of Care Level of Care HC 3s 1 25 0 0 1 25 2 50 4 100 HC 4s 3 3 HC 4s 13 37 7 20 6 17 9 26 35 100 Gen Hosp 3 3 Gen Hosp 10 33 10 33 5 17 5 17 30 100 RRH 1 1 RRH 1 17 3 50 1 17 1 17 6 100 Total 7 7 NRH 0 0 1 100 0 0 0 0 1 100 Total 25 33 21 28 13 17 17 22 76 100 Ownership Comments: GeneXepert Catridges Government 21 32 18 27 12 18 15 23 66 100 •33% of the health facilities were stocked-out (0 MoS) PNFP 4 40 3 30 1 10 2 20 10 100 •22% of the health facilities were overstocked (> 4 MoS). Total 25 33 21 28 13 17 17 22 76 100 •There were no expiries reported for GeneXepert Catridges

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty Blood 450 ml Blood 450 ml Blood 450 ml Level of Care Level of Care Level of Care HC 4s 38 70 14 26 1 2 1 2 54 100 HC 4s 2 8 Gen Hosp 16 57 11 39 1 4 0 0 28 100 Gen Hosp 4 60 RRH 0 0 4 100 0 0 0 0 4 100 RRH 2 52 Total 54 63 29 34 2 2 1 1 86 100 Total 8 120

Ownership Comments: Blood 450 ml Government 39 65 18 30 2 3 1 2 60 100 •54% of the health facilities were stocked-out (0 MoS) PNFP 15 58 11 42 0 0 0 0 26 100 •Masindi Military Barracks HC IV, reported on overstocked (> 4 MoS) and no facility with over 8 MoS Total 54 63 29 34 2 2 1 1 86 100 •A total of 8 health facilities reported on 120 (450ml) of blood as quantity expired. They include; Moroto and Kabale Regional RH, Kidera HC IV, Anyeke HC IV, Bombo General Military Hospital, Kuluva Hospital, Rugarama Hospital and Bwindi Community Hospital.

TB BASKET

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per blister No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) (RHZE) blister strip 150/75/400/275 mg (RHZE) blister strip 150/75/400/275 mg (RHZE) blister strip 150/75/400/275 mg Level of Care Level of Care Level of Care HC 3s 49 16 76 25 70 23 110 36 305 100 HC 3s 54 12 66 HC 3s 7 16,539 31,490 HC 4s 11 16 17 25 10 15 31 45 69 100 HC 4s 10 3 13 HC 4s 3 5,056 9,627 Gen Hosp 5 11 14 30 8 17 19 41 46 100 Gen Hosp 6 8 14 Gen Hosp 2 34 65 RRH 0 0 0 0 2 50 2 50 4 100 RRH 1 0 1 Total 12 21,629 41,182 NRH 0 0 0 0 1 100 0 0 1 100 Total 71 0 23 94 Total 65 15 107 25 91 21 162 38 425 100 Ownership Comments: (RHZE) blister strip 150/75/400/275 mg Government 44 13 85 26 73 22 129 39 331 100 •15% of the health facilities were stocked-out (0 MoS) PFP 1 25 3 75 0 0 0 0 4 100 •38% of the facilities were overstocked (> 4 MoS). Govt owned HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 20 22 19 21 18 20 33 37 90 100 •A total of 12 health facilities reported on 21,629 blister strips as quantity expired. Value of unit cost $ 41,182 Total 65 15 107 25 91 21 162 38 425 100

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per blister No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) RHZ Blister 75mg/50mg/150mg RHZ Blister 75mg/50mg/150mg RHZ Blister 75mg/50mg/150mg Level of Care Level of Care Level of Care HC 3s 101 46 47 21 21 10 51 23 220 100 HC 3s 32 6,394 8,056 HC 4s 16 41 11 28 8 21 4 10 39 100 HC 4s 9 5,323 6,707 Gen Hosp 8 30 5 19 5 19 9 33 27 100 Gen Hosp 6 672 847 RRH 1 25 1 25 1 25 1 25 4 100 RRH 3 378 476 Total 126 43 64 22 35 12 65 22 290 100 Total 50 12,767 16,086

Ownership Comments: RHZ Blister 75mg/50mg/150mg Government 95 42 51 22 27 12 55 24 228 100 •43% of the health facilities were stocked-out (0 MoS) PFP 2 100 0 0 0 0 0 0 2 100 •22% of the health facilities were overstocked (> 4 MoS). And there were no facilities with over 8 MoS PNFP 29 48 13 22 8 13 10 17 60 100 • A total of 50 health facilities reported on 12,767 Blisters as quantity expired. Value of unit cost ugx 16,086 Total 126 43 64 22 35 12 65 22 290 100

April 2020 Facility Stock Status Report 10 of 10